McCarley D J, Parsons J T, Benjamin D C, Parsons S J
J Virol. 1987 Jun;61(6):1927-37. doi: 10.1128/JVI.61.6.1927-1937.1987.
A monoclonal antibody, R2D2, raised to the src gene product of Rous sarcoma virus was found to inhibit the tyrosine protein kinase activity of pp60v-src in autophosphorylation reactions and in reactions involving exogenously added substrates, such as casein and histone. R2D2 also inhibited the enzymatic activity of two related viral transforming proteins, pp70gag-fgr and pp90gag-yes. The inhibitory ability of R2D2 was dependent upon immunoglobulin concentration and could be demonstrated in both immune complexes formed directly with R2D2 and preformed immune complexes to which R2D2 was added. Binding sites in both the amino-terminal 110 amino acid residues and the carboxy-terminal 240 amino acids of pp60v-src were identified for R2D2. These results indicate that at least part of the epitope recognized by R2D2 resides within a region of the src protein which is required for protein kinase activity. The localization of the R2D2 epitope to the amino- as well as to the carboxy-terminal portions of pp60v-src, together with results of studies analyzing the relative binding efficiencies of R2D2 to the intact protein and to V-8 proteolytic fragments of pp60v-src, are consistent with the view that the R2D2 epitope is conformational in nature and that it is assembled from residues contained within both N-terminal and C-terminal regions of the molecule.
一种针对劳氏肉瘤病毒src基因产物产生的单克隆抗体R2D2,被发现能在自身磷酸化反应以及涉及外源添加底物(如酪蛋白和组蛋白)的反应中抑制pp60v-src的酪氨酸蛋白激酶活性。R2D2还抑制了两种相关病毒转化蛋白pp70gag-fgr和pp90gag-yes的酶活性。R2D2的抑制能力取决于免疫球蛋白浓度,并且在直接与R2D2形成的免疫复合物以及添加了R2D2的预先形成的免疫复合物中都能得到证明。确定了pp60v-src的氨基末端110个氨基酸残基和羧基末端240个氨基酸中R2D2的结合位点。这些结果表明,R2D2识别的表位至少部分位于src蛋白中蛋白激酶活性所需的区域内。R2D2表位在pp60v-src的氨基末端和羧基末端部分的定位,以及分析R2D2与完整蛋白和pp60v-src的V-8蛋白酶水解片段的相对结合效率的研究结果,都与R2D2表位本质上是构象性的观点一致,并且它是由分子的N末端和C末端区域内包含的残基组装而成的。